Trial intelligence / Profile preview

AN2728 (crisaborole) in mild-to-moderate plaque-type psoriasis

NCT01300052Phase 2Completed

Sponsor
Pfizer
Start
Jan 2011
Primary completion
Jun 2011
Countries
1
01

Overview

A Phase 2 trial of AN2728 ointment vehicle in plaque psoriasis, sponsored by Pfizer. Started Jan 2011; status: completed.

02

Drugs

AN2728 ointment vehicle
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01300052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01300052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call